JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online May 15, 2008, 10.2967/jnmt.107.049023
doi:10.2967/jnmt.107.049023
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnmt.107.049023v1
36/2/95    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willett, A. B.
Right arrow Articles by Grantham, V. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willett, A. B.
Right arrow Articles by Grantham, V. V.
Journal of Nuclear Medicine Technology Volume 36, Number 2, 2008 95-98
© 2008 by Society of Nuclear Medicine

Determination of Hemolytic Anemia Through the Study of 51Cr Red Cell Survival and Splenic Sequestration

Audrey B. Willett and Vesper V. Grantham

Department of Medical Imaging and Radiation Sciences, College of Allied Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Correspondence: For correspondence or reprints contact: Vesper Grantham, University of Oklahoma Health Sciences Center, P.O. Box 26901/CHB 451, Oklahoma City, OK 73190. E-mail: vesper-grantham{at}ouhsc.edu

ABSTRACT

The use of 51Cr-labeled red blood cells to determine erythrocyte survival in circulation is not a routine procedure. Data are acquired by frequent counting of small-volume blood samples to determine the rate of red cell survival over time. Results are entirely quantitative and can involve semilogarithmic graphing techniques. An accurate study can positively identify hemolytic anemia, a disorder characterized by premature destruction of erythrocytes. Additionally, anatomic sites of premature hemolysis will demonstrate a higher radioactive count than the background organ. This procedure review presents a dual survival and sequestration study positive for hemolytic anemia and hypersplenism in an 83-y-old man with systemic lupus erythematosus. 51Cr red cell survival and splenic sequestration studies may be considered when clinical history and laboratory studies cannot establish a definitive diagnosis.

Key Words: hemolytic anemia; red cell survival; splenic sequestration







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2008 by the Society of Nuclear Medicine Technologist Section.